(Q42978294)

12 November 2017

Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis (English)

1 reference

12 November 2017

Tsai JF

1

1 reference

12 November 2017

Jeng JE

2

1 reference

12 November 2017

Ho MS

3

1 reference

12 November 2017

Chang WY

4

1 reference

12 November 2017

Lin ZY

5

1 reference

12 November 2017

Tsai JH

6

1 reference

12 November 2017

language of work or name

1 reference

1 March 1996

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

24

1 reference

12 November 2017

271-276

1 reference

12 November 2017

3

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Epidemiology and long term prognosis of hepatitis C virus infection in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Circulating immune complexes in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Natural history of chronic hepatitis B virus infection: new light on an old story.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Hepatocellular carcinoma in 13 patients with hepatitis C virus-associated chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Etiology of chronic hepatitis in France: predominant role of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Antibodies to hepatitis E and A viruses among patients with non-alcoholic chronic liver disease in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980004-3

7 January 2021

10.1016/S0168-8278(96)80004-3

Identifiers

DOI

1 reference

12 November 2017

1 reference